Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Discover the complete record of transactions filed by Mcdonnell Michael R, Chief Financial Officer. Director active across 3 companies, notably BIOGEN INC.. Cumulatively, 17 filings have been logged. Split: 0 buy · 1 sell. Total volume traded: €145k. History available since 1 September 2021. The latest transaction was disclosed on 13 February 2026 (Attribution). Regulator: SEC (Form 4). All data is openly available.
Companies and markets linked to Mcdonnell Michael R
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
2,681 shares@ US$338.24100.0% of flowCommon StockSEC:0001127602-21-024863:0
17 of 17 declarations
About Mcdonnell Michael R
Michael R. McDonnell is Chief Financial Officer. He has 17 filings in total, and across the 17 recent filings available, the aggregated volumes show EUR 145034 of sales and EUR 0 of purchases, with a date range from 2021-09-03 to 2026-02-18. The companies listed for him are BIOGEN INC., Merit Medical Systems INC and Baxter International INC.